Change Control · Risk Assessment
A change-control approval should show why the organization believed the change was acceptable before implementation.
A defensible change record connects the proposed change to its evidence, impact assessment, risk judgment, implementation conditions, and accountable authorization—not just the fact that the workflow reached “approved.”
The decision boundary
The approval is only as reviewable as the impact and risk reasoning behind it.
What evidence supported the change, what could be affected, what risk remained, and who authorized proceeding?
What the record should make reviewable
Evidence
Technical rationale, validation or qualification evidence, process history, product knowledge, supplier or equipment information, and other facts supporting the proposed change.
Impact & judgment
Assessment of product quality, validated state, regulatory commitments, procedures, training, data systems, supply, and other affected controls—and why the proposed controls are sufficient.
Risk & authorization
Uncertainty, failure modes, residual exposure, implementation conditions, monitoring or effectiveness checks, and the accountable authorization to proceed.
FDA / ICH context
Quality risk management should support the decision—not become a score with no visible reasoning.
Q9(R1) identifies risk-based decision-making and subjectivity in risk assessment outputs as areas requiring clarity. For change control, that makes the documented reasoning behind risk conclusions important: a later reviewer should be able to understand how the evidence and uncertainty led to the approved path.
Test the authorization basis
Can another qualified reviewer understand why this change was approved?
Use the existing detailed change-control documentation guide for the record structure, or assess one completed change-control decision through the DDA.